Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2015 / Articles / May / The Power of the List
Business & Regulation Business Practice Trends & Forecasts

The Power of the List

Celebrating medicine makers of all stripes in our Top 100

By Charlotte Barker 05/05/2015 1 min read

Share

The nominations are in, the votes have been counted. After considerable debate, detailed analysis, and some inspiration from The Beatles, we present The Medicine Maker Power List 2015 – our index of the 100 most influential people in the field.

The list was developed in three stages. In stage one, we invited readers to nominate those who they thought deserved recognition. In stage two, a jury of four noted medicine makers (who prefer to remain anonymous) selected their top 100 from the slate of nominees: the results were consolidated into a list of 100 names. In the final stage, the jury ranked the list, and the average rankings were combined to provide the final Power List. We make no claims that this is a definitive list – there really can be no such thing. We don’t expect that all of our 20,000 print and 60,000 online readers will agree with who’s on the list, let alone the order of the Top 20. So why make a list at all? In the immortal words of Kool and the Gang, it’s a celebration. We want to recognize the achievements of the field’s big hitters and unsung heroes alike – please do let us know of any glaring omissions you’d like to see recognized on the next list. I hope we can all agree on one thing: that celebrating the achievements of peers and colleagues is good for the industry. There were some disappointments, with only eight women on this year’s list, and a lack of cultural diversity. We hope to see those statistics change over the years, and we would welcome your feedback on how we can better serve under-represented groups.

That said, we were pleasantly surprised by the huge range of sectors and job roles encompassed in your nominations. We asked you to cast your net wide, and you obliged, putting forward everyone from Nobel Prize-winning scientists to leaders of global corporations, not forgetting payers, philanthropists and entrepreneurs. They may not all be traditional medicine makers, working in pharmaceutical development or manufacturing, but they all contribute to bringing medicines to patients. And after all, that is what this industry, and The Medicine Maker, is all about. To all those who participated, our thanks. To those who feel aggrieved, let us know. And to those who made it into the Top 100, congratulations! Finally, please enjoy The Power List!

Charlotte Barker
Editor

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

More Articles by Charlotte Barker

False

Advertisement

Recommended

False

Related Content

What Trump’s Latest Moves Mean for the Industry
Business Practice Standards & Regulation Trends & Forecasts Bioprocessing - Upstream & Downstream
What Trump’s Latest Moves Mean for the Industry

May 27, 2025

6 min read

Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.

Big Bad Pharma?
Business Practice Trends & Forecasts
Big Bad Pharma?

December 1, 2014

0 min read

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Access All Areas
Business Practice Trends & Forecasts
Access All Areas

December 1, 2014

0 min read

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Care to ‘Patent Dance’?
Business Practice Trends & Forecasts
Care to ‘Patent Dance’?

December 1, 2014

0 min read

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.